CIM
CORT icon

CIM Investment Management’s Corcept Therapeutics CORT Stock Holding History

CIM Investment Management’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-9,589
Closed -$246K – 251
2022
Q3 		$246K Hold
9,589
– – 0.11% 178
2022
Q2 		$228K Hold
9,589
– – 0.09% 191
2022
Q1 		$216K Sell
9,589
-1,124
-10% -$23.9K 0.07% 224
2021
Q4 		$212K Hold
10,713
– – 0.06% 276
2021
Q3 		$211K Hold
10,713
– – 0.07% 278
2021
Q2 		$236K Hold
10,713
– – 0.07% 261
2021
Q1 		$255K Sell
10,713
-643
-6% -$17.2K 0.08% 240
2020
Q4 		$297K Hold
11,356
– – 0.1% 208
2020
Q3 		$198K Sell
11,356
-11,034
-49% -$176K 0.08% 240
2020
Q2 		$377K Sell
22,390
-5,412
-19% -$76K 0.15% 135
2020
Q1 		$331K Buy
27,802
+9,091
+49% +$113K 0.16% 126
2019
Q4 		$226K Sell
18,711
-14,620
-44% -$204K 0.09% 191
2019
Q3 		$471K Hold
33,331
– – 0.18% 135
2019
Q2 		$372K Sell
33,331
-695
-2% -$7.74K 0.14% 186
2019
Q1 		$399K Sell
34,026
-289
-0.8% -$3.59K 0.15% 177
2018
Q4 		$458K Buy
34,315
+17,602
+105% +$233K 0.2% 114
2018
Q3 		$234K Hold
16,713
– – 0.08% 299
2018
Q2 		$263K Buy
+16,713
New +$291K 0.09% 294

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CIM Investment Management's CORT Position: Q4 2022 in Review

CIM Investment Management sold out of Corcept Therapeutics (CORT) in Q4 2022, closing a stake of 9,589 shares — an estimated $246K sold.

CIM Investment Management first reported a position in CORT in Q2 2018 and held it in 18 quarters. The position peaked at $471K in Q3 2019. 241 funds tracked by Wall St. Rank hold CORT as of Q4 2022.

  • CIM Investment Management reported no remaining Corcept Therapeutics position as of Q4 2022 after selling out during the quarter.
  • CIM Investment Management sold 9,589 Corcept Therapeutics shares in Q4 2022, an estimated $246K.
  • CIM Investment Management first reported a position in Corcept Therapeutics in Q2 2018 and held it in 18 quarters.
  • CIM Investment Management's Corcept Therapeutics position peaked at $471K in Q3 2019.
  • 241 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q4 2022.

Based on CIM Investment Management's 13F filing for Q4 2022, filed 14 Feb 2023.